SF
LH icon

Summit Financial’s Labcorp LH Stock Holding History

Summit Financial’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
+885
New +$233K ﹤0.01% 1420

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Summit Financial's LH Position: Q2 2026 in Review

Summit Financial opened a new position in Labcorp (LH) in Q2 2026: 885 shares worth $248K. The stake represents ﹤0.01% of the portfolio and ranks #1420 among its holdings.

1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Summit Financial held 885 shares of Labcorp worth $248K as of Q2 2026.
  • Labcorp was a new Summit Financial position in Q2 2026.
  • Labcorp made up ﹤0.01% of Summit Financial's portfolio in Q2 2026, its #1420 holding.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.